Listed by the USPTO as KOSTURKO, GEORGE W
Tech Center 1600 • Art Units: 1621 1628
This examiner grants 55% of resolved cases
KOSTURKO, GEORGE W has resolved 736 cases in Tech Center 1600 and art unit 1621. The allowance rate is 54.6%, and the median time to allowance is 995 days. The interview lift is 48.9%, showing a strong association between interviews and allowance outcomes.
The represented companies include Genentech Inc., Hoffmann-La Roche Inc., and The Regents of the University of Michigan. The leading firms are Casimir Jones, S.C., DERGOSITS & NOAH LLP, and Giordano Law LLC. The substantial record supports giving the interview figure significant weight, particularly where written prosecution alone has not resolved the key issues.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18817828 | TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES COMPRISING AN ATP COMPETITIVE AKT INHIBITOR, A CDK4/6 INHIBITOR, AND FULVESTRANT | Non-Final OA | Genentech, Inc. |
| 18702989 | CRYSTALLINE FORMS OF QUINAZOLINE DERIVATIVES, PREPARATION, COMPOSITION AND USE THEREOF | Non-Final OA | Hoffmann-La Roche Inc. |
| 18271102 | METHODS FOR PREVENTING OR TREATING CONDITIONS RELATED TO T CELL MEDIATED INTESTINAL DISORDERS | Final Rejection | The Regents of the University of Michigan |
| 18800173 | CARDIO- AND RENOSAFE ANTIDIABETIC THERAPY | Non-Final OA | Boehringer Ingelheim International GmbH |
| 18790166 | ANTIVIRAL COMPOSITIONS AND METHODS FOR INACTIVATING NON-ENVELOPED VIRUSES USING ALKYL 2-HYDROXYCARBOXYLIC ACIDS | Non-Final OA | ECOLAB USA INC. |
| 18643207 | PHARMACEUTICAL COMPOSITIONS FOR TREATING CYSTIC FIBROSIS | Final Rejection | Vertex Pharmaceuticals Incorporated |
| 18854031 | LRRK2 Inhibitors | Non-Final OA | Brenig Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy54.6% of resolved applications examined by George W Kosturko were allowed (736 resolved cases), compared with 46.7% across Art Unit 1621 over the last five years.
This examiner's interview lift is +48.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by George W Kosturko took 995 days on average from filing to allowance.
George W Kosturko examines applications in Art Unit 1621 in Tech Center 1600 (Biotechnology & Pharmaceuticals).